Future Trends in the Pharmacogenomics of Brain Disorders and Dementia: Influence of APOE and CYP2D6 Variants
About 80% of functional genes in the human genome are expressed in the brain and over 1,200 different genes have been associated with the pathogenesis of CNS disorders and dementia. Pharmacogenetic studies of psychotropic drug response have focused on determining the relationship between variations...
Saved in:
Main Authors: | Antón Álvarez (Author), Verónica Couceiro (Author), Susana Rodríguez (Author), Ángela Casas (Author), Margarita Alcaraz (Author), Laura Nebril (Author), Iván Tellado (Author), Iván Carrera (Author), Lola Corzo (Author), Valter Lombardi (Author), Adam McKay (Author), Juan C. Carril (Author), Ramón Cacabelos (Author), Rocío Martínez-Bouza (Author), Lucía Fernández-Novoa (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2010-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Influence of Pathogenic and Metabolic Genes on the Pharmacogenetics of Mood Disorders in Alzheimer's Disease
by: Ramón Cacabelos, et al.
Published: (2021) -
Natural Bioactive Products as Epigenetic Modulators for Treating Neurodegenerative Disorders
by: Olaia Martínez-Iglesias, et al.
Published: (2023) -
Neuroprotective Effect of Nosustrophine in a 3xTg Mouse Model of Alzheimer's Disease
by: Iván Carrera, et al.
Published: (2023) -
Nosustrophine: An Epinutraceutical Bioproduct with Effects on DNA Methylation, Histone Acetylation and Sirtuin Expression in Alzheimer's Disease
by: Olaia Martínez-Iglesias, et al.
Published: (2022) -
Immunocytochemical Characterization of Alzheimer's Disease Hallmarks in APP/PS1 Transgenic Mice Treated with a New Anti-Amyloid-β Vaccine
by: Ivan Carrera, et al.
Published: (2014)